Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B E Ilson

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Critical Care Clinics|October 1, 1987
Acute metabolic acid-base disordersL J Riley, B E Ilson, R G Narins
The Journal of Clinical Endocrinology and Metabolism|July 1, 1989
Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjectsB E Ilson, D K Jorkasky, R T Curnow, et al.
Journal of Clinical Pharmacology|May 29, 1998
The effects of eprosartan, an angiotensin II AT1 receptor antagonist, on uric acid excretion in patients with mild to moderate essential hypertensionB E Ilson, D E Martin, S C Boike, et al.
Pharmacotherapy|May 20, 1999
Pharmacokinetics and protein binding of eprosartan in hemodialysis-dependent patients with end-stage renal diseaseS J Kovacs, D M Tenero, D E Martin, et al.
Hospital Practice (Office Ed.)|October 15, 1990
Metabolic acidosis in a diabetic manB E Ilson, P S Bland, N L Allison, et al.
Clinical Pharmacology and Therapeutics|May 20, 1998
A dose-response study to assess the renal hemodynamic, vascular, and hormonal effects of eprosartan, an angiotensin II AT1-receptor antagonist, in sodium-replete healthy menB E Ilson, S C Boike, D E Martin, et al.
Clinical Pharmacology and Therapeutics|May 26, 1999
Pharmacokinetics and pharmacodynamics of SB 209670, an endothelin receptor antagonist: effects on the regulation of renal vascular toneM I Freed, D E Wilson, K A Thompson, et al.
Journal of Clinical Pharmacology|May 23, 1998
A dose proportionality study of eprosartan in healthy male volunteersM C Chapelsky, D E Martin, D M Tenero, et al.
Journal of Clinical Pharmacology|December 1, 1994
Pharmacokinetics of famciclovir in subjects with chronic hepatic diseaseS C Boike, M Pue, P R Audet, et al.
Journal of Clinical Pharmacology|February 1, 1997
Eprosartan, an angiotensin II receptor antagonist, does not affect the pharmacodynamics of glyburide in patients with type II diabetes mellitusD E Martin, G S DeCherney, B E Ilson, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Critical Care Clinics|October 1, 1987
Acute metabolic acid-base disordersL J Riley, B E Ilson, R G Narins
The Journal of Clinical Endocrinology and Metabolism|July 1, 1989
Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjectsB E Ilson, D K Jorkasky, R T Curnow, et al.
Journal of Clinical Pharmacology|May 29, 1998
The effects of eprosartan, an angiotensin II AT1 receptor antagonist, on uric acid excretion in patients with mild to moderate essential hypertensionB E Ilson, D E Martin, S C Boike, et al.
Pharmacotherapy|May 20, 1999
Pharmacokinetics and protein binding of eprosartan in hemodialysis-dependent patients with end-stage renal diseaseS J Kovacs, D M Tenero, D E Martin, et al.
Hospital Practice (Office Ed.)|October 15, 1990
Metabolic acidosis in a diabetic manB E Ilson, P S Bland, N L Allison, et al.
Clinical Pharmacology and Therapeutics|May 20, 1998
A dose-response study to assess the renal hemodynamic, vascular, and hormonal effects of eprosartan, an angiotensin II AT1-receptor antagonist, in sodium-replete healthy menB E Ilson, S C Boike, D E Martin, et al.
Clinical Pharmacology and Therapeutics|May 26, 1999
Pharmacokinetics and pharmacodynamics of SB 209670, an endothelin receptor antagonist: effects on the regulation of renal vascular toneM I Freed, D E Wilson, K A Thompson, et al.
Journal of Clinical Pharmacology|May 23, 1998
A dose proportionality study of eprosartan in healthy male volunteersM C Chapelsky, D E Martin, D M Tenero, et al.
Journal of Clinical Pharmacology|December 1, 1994
Pharmacokinetics of famciclovir in subjects with chronic hepatic diseaseS C Boike, M Pue, P R Audet, et al.
Journal of Clinical Pharmacology|February 1, 1997
Eprosartan, an angiotensin II receptor antagonist, does not affect the pharmacodynamics of glyburide in patients with type II diabetes mellitusD E Martin, G S DeCherney, B E Ilson, et al.
Pageof 2